Terumo Corp.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Sep 22, 2017
Prev close: 4,505
Sep 22, 2017
Market cap:
Market cap(USD):
1,710.82B
15,285.4M
Shares: 379.76M

Currency in JPY

Company profile

Market(Ticker): TKS(4543)
Sector:
Industry:
Health Technology
Medical Specialties
Full time employees: 22,441

Business summary

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management. The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home medical treatment, and peritoneal dialysis and diabetes-related products. The Cardiac & Vascular segment imports and merchandises catheter and cardiovascular systems products. The Blood Management segment manufactures and sells blood transfusion products such as blood bags and automated blood component processing devices. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

In the news

Financial highlights

Mar 2017

  • Local currency
  • US Dollar
Revenue 514,164M
Gross profit 276,889M
Operating income 75,468M
Income before tax 74,981M
Net income 54,225M
EBITDA 121,979M
Diluted EPS 140.04
Dividends per share 42
Total assets 1,021.40B
Total liabilities 531,847M
Total equity 489,453M
Operating cash flow 80,862M

Currency in JPY

Revenue 4,748.13M
Gross profit 2,556.98M
Operating income 696.92M
Income before tax 692.42M
Net income 500.75M
EBITDA 1,126.43M
Diluted EPS 1.29
Dividends per share 0.38
Total assets 9,166.33M
Total liabilities 4,772.92M
Total equity 4,392.47M
Operating cash flow 746.73M

Currency in USD

Valuation measures

Mar 2017

PER 25.74
ROA 5.63%
ROE 10.83%
Operating margin 14.67%
Profit margin 10.54%

Key executive

  • President, CEO & Representative Director: Shinjiro Sato
  • Chief Accounting & Financial Officer: Ryo Nishihata
  • Chief Clinical & Regulatory Affairs Officer: Kazuhisa Senshu
  • CTO, Executive Officer, GM-Research & Development: Hiroaki Kasukawa
  • Executive Officer & Chief Information Officer: Katsuya Takeuchi

Share holders

  • Terumo Corp.(7.3%)
  • Massachusetts Financial Services Co.(7.1%)
  • Nomura Asset Management Co., Ltd.(6.7%)
  • Dai-ichi Life Holdings, Inc.(4.5%)
  • Asset Management One Co., Ltd.(4.1%)
  • Meiji Yasuda Life Insurance Co.(3.5%)
  • Mitsubishi UFJ Financial Group, Inc.(3.4%)
  • Nikko Asset Management Co., Ltd.(3.3%)
  • Daiwa Asset Management Co. Ltd.(2.8%)
  • BlackRock Fund Advisors(2.7%)

Address

  • Website: http://www.terumo.co.jp
  • Address: 2-44-1 Hatagaya, Shibuya-Ku, Tokyo, 151-0072, Japan
  • Phone: +81.3.3374.8111

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.